Fuzapladib (sodium), CAS [[141284-73-3]]

Produktübersicht

• Artikelname: Fuzapladib (sodium), CAS [[141284-73-3]]
• Artikelnummer: MCE-HY-19151A
• Hersteller Artikelnummer: HY-19151A
• Alternativnummer: MCE-HY-19151A-100MG,MCE-HY-19151A-5MG,MCE-HY-19151A-10MMX1ML,MCE-HY-19151A-10MG,MCE-HY-19151A-50MG,MCE-HY-19151A-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: IS-741 (sodium)

Produktbeschreibung

Fuzapladib (IS-741) sodium, an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib sodium is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib sodium exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].

Produkteigenschaften

• Molekulargewicht: 402.39
• Reinheit: 99.61
• CAS Nummer: [141284-73-3]
• Formel: C15H20F3N3NaO3S
• Target-Kategorie: Integrin,Phospholipase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound